Stay updated with breaking news from Denise Faustman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers conducted a Phase III trial to test the 100-year-old Bacillus Calmette-Gu rin (BCG) vaccine in people with type 1 diabetes during the COVID-19 pandemic.
Studies suggest the BCG jab discovered a century ago could provide a cheap and effective way of boosting the immune system to protect people from developing the condition
The FDA recently approved the first cellular therapy for Type 1 diabetes and others may not be far behind. But experts say challenges still exist to the widespread application of these treatments.
The BCG vaccine might help prevent a range of major diseases
The Bacillus-Calmette-Guerin vaccine has long been known to have broad effects on the immune system, and is still given to infants in the developing world and in countries where TB is prevalent.